Delivery Order SPE2DB22D2108-SPE2DB25FU3AX
Award Date
1/2/25
Potential Completion Date
1/3/25
Potential Value
$6.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,565,308,643 units of the drug dapagliflozin 10 mg tablets in 30-count packages. The contract has a ceiling value of $6,075.89 and an ultimate completion date of August 1, 2024. This contract is not set aside for any specific business category. Amerisourcebergen holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is for the delivery of 4,564,755,292 units of Dapagliflozin 10 mg tablets. The contract, valued at $16,574.98, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD).
Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,067.27, is for the delivery of dapagliflozin 10 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a federal delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,565,254,962 units of the pharmaceutical drug dapagliflozin 10 mg tablets. The award has a ceiling value of $25,926.70 and a completion date of July 26, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide these essential medical products to support military...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for 4,566,503,281 units of the diabetes medication Dapagliflozin 5 mg tablets. The $1,447.39 contract has a completion date of November 21, 2024.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,564,667,882 dapagliflozin 10 mg tablets. The $1,993.95 firm fixed-price contract has a completion date of May 22, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,335.46 firm fixed-price delivery order is for the supply of 4,565,548,469 tablets of the drug Dapagliflozin 10 mg, with a period of performance through August 23, 2024.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,601.54 firm-fixed-price delivery order is for the supply of 4,566,150,890 units of the medication Dapagliflozin 10 mg tablets. The contract has an ultimate completion date of October 21, 2024 and was awarded on October 18, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a $1,224.71 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,840 units of dapagliflozin 10 mg tablets. The contract has a period of performance through September 18, 2024 and was awarded on September 17, 2022. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities, veterans' hospitals, and other...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,032,557 units of the pharmaceutical product dapagliflozin 10 mg tablet in 30-count packages. The contract has a ceiling value of $14,715.72 and a completion date of July 1, 2024. The contract was awarded on June 28, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a major component of the Department of Defense (DoD) that provides logistics and acquisition...